tiprankstipranks
Trending News
More News >
China Shineway Pharmaceutical Group Limited (HK:2877)
:2877
Hong Kong Market
Advertisement

China Shineway Pharmaceutical Group Limited (2877) Income Statement

Compare
0 Followers

China Shineway Pharmaceutical Group Limited Income Statement

Last quarter (Q4 2024), China Shineway Pharmaceutical Group Limited's total revenue was ¥1.69B, a decrease of -20.80% from the same quarter last year. In Q4, China Shineway Pharmaceutical Group Limited's net income was ¥213.57M. See China Shineway Pharmaceutical Group Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 3.78B¥ 4.52B¥ 3.95B¥ 3.22B¥ 2.66B
Gross Profit
¥ 2.83B¥ 3.39B¥ 2.94B¥ 2.41B¥ 1.99B
Operating Expenses
¥ 1.99B¥ 2.42B¥ 2.12B¥ 1.79B¥ 1.71B
Depreciation and Amortization
¥ 165.89M¥ 177.10M¥ 185.86M¥ 182.39M¥ 208.41M
EBITDA
¥ 1.00B¥ 1.42B¥ 1.10B¥ 903.74M¥ 620.04M
Operating Income
¥ 842.60M¥ 975.53M¥ 713.58M¥ 534.37M¥ 422.40M
Other Income/Expenses
¥ 303.12M¥ 264.72M¥ 203.45M¥ 185.74M¥ -27.37M
Pretax Income
¥ 1.15B¥ 1.24B¥ 917.02M¥ 720.10M¥ 395.02M
Net Income
¥ 840.05M¥ 969.51M¥ 722.77M¥ 556.67M¥ 295.03M
Per Share Metrics
Basic EPS
¥ 1.11¥ 1.28¥ 0.96¥ 0.74¥ 0.39
Diluted EPS
¥ 1.11¥ 1.28¥ 0.96¥ 0.74¥ 0.39
Weighted Average Shares Outstanding
756.80M 757.43M 755.40M 755.14M 756.49M
Weighted Average Shares Outstanding (Diluted)
755.40M 755.40M 755.40M 755.14M 756.75M
Currency in CNY

China Shineway Pharmaceutical Group Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis